Oncology
2 drugs are in development for NMIBC.
- Companies
- 1
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the NMIBC pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(2)
| Drug | Company |
|---|---|
| ugn-301 | UroGen Pharma Ltd. (URGN) |
| ugn-501 | UroGen Pharma Ltd. (URGN) |
About this indication
NMIBC context
Oncology·MeSH: Non-Muscle Invasive Bladder Neoplasms (D000093284)
Also known as: Bladder Cancer, Non-Muscle-Invasive, Bladder Cancers, Non-Muscle-Invasive, Non Muscle Invasive Bladder Neoplasms
Frequently asked questions
How many drugs are in development for NMIBC?
BioSniper tracks 2 drugs in development for NMIBC across 1 company.
How many clinical trials target NMIBC?
There are 9 clinical trials targeting NMIBC tracked by BioSniper.